Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 05, 2018
AcuityBio has entered into agreements with Cook Biotech.
read more
Monday, September 30, 2024
Acumen Pharmaceuticals, Inc. announced that it has extended its collaboration with Lonza to enable the potential future commercial launch of sabirnetug (ACU193).
read more
Friday, September 13, 2019
Acura Pharmaceuticals has engaged Catalent to initiate manufacturing scale-up of LTX-03 Tablets to ultimately be used in clinical testing.
read more
Acurian, Inc., a leading, full-service provider of global patient enrollment and retention solutions, announced today it has agreed to a two-year partnership with the Society for Clinical Research Sites (SCRS), based in Rockville, MD.
read more
Acurian and Synexus have launched SynexusPlus, an integrated site solution for enrolling patients in clinical studies.
read more
Adams Clinical Site Network, a Neuroscience-focused clinical trial site network announced today that Dr. Colin Sauder, PhD has joined the company as Chief Scientific Officer. In his role, Dr. Sauder will oversee clinical and operational teams ...
read more
Wednesday, October 09, 2019
Adaptimmune Therapeutics and Cryoport announced a three-year agreement to ensure fully monitored transport of Adaptimmune’s cell therapies.
read more
AGC Biologics is partnering with AdaptVac to develop and produce a COVID-19 vaccine.
read more
Adare Pharmaceuticals has entered into an agreement with Egalet, to acquire global rights of the “Parvulet™” technology platform and its associated Intellectual Property.
read more
Adare Pharmaceuticals has acquired pharmaceutical technology company, Orbis Biosciences.
read more
Tuesday, October 08, 2024
Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced a collaboration with Laxxon Medical, a pharma-technology company pioneering a new generation of advanced pharmaceuticals, to provide the ...
read more
Adare Pharma Solutions has announced expansions of its high potency handling capabilities in the United States and Europe. In the United States, a second high potency suite is being added to Adare’s 128,000 sq ft (12,000 sq m) Orthodox Street ...
read more
Wednesday, January 27, 2021
Adare Pharma Solutions has announced the opening of a new small-scale development laboratory in Vandalia, Ohio.
read more
Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the development and manufacturing of postbiotics, to dsm-firmenich, ...
read more
Adare Pharma Solutions announces that Ludger Roedder has joined the organization as President of Adare Biome.
read more